The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of MEK inhibitor selumetinib in combination with azacitidine in patients with higher-risk chronic myeloid neoplasia.
 
Gregory Roloff
No Relationships to Disclose
 
Anand Ashwin Patel
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb/Celgene
Research Funding - Kronos Bio (Inst); Pfizer (Inst)
 
Kristen M Pettit
Consulting or Advisory Role - Abbvie; CTI BioPharma Corp; Incyte; Sierra Oncology
Research Funding - Abbvie (Inst); Blueprint Medicines (Inst); CTI BioPharma Corp (Inst); Imago Biosciences (Inst); Kura Oncology (Inst); MacroGenics (Inst); PharmaEssentia (Inst); Protagonist Therapeutics (Inst)
 
Michael J. Thirman
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; AstraZeneca; Celgene; Genentech; Pharmacyclics
Research Funding - Abbvie (Inst); Merck (Inst); Syndax (Inst); TG Therapeutics (Inst)
 
Richard A. Larson
Consulting or Advisory Role - AbbVie; Actinium Pharmaceuticals; Curis; CVS Caremark; Epizyme; Immunogen; Jazz Pharmaceuticals; Kling Biotherapeutics; Novartis; Rigel; SERVIER; Takeda Science Foundation
Research Funding - Astellas Pharma (Inst); Celgene (Inst); Cellectis (Inst); Daiichi Sankyo (Inst); Gilead/Forty Seven; Novartis (Inst); Rafael Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
 
Mariam Nawas
No Relationships to Disclose
 
Satyajit Kosuri
No Relationships to Disclose
 
Michael William Drazer
Consulting or Advisory Role - argenx; Cardinal Health
 
Noreen Fulton
No Relationships to Disclose
 
Howard Weiner
No Relationships to Disclose
 
Wendy Stock
Honoraria - Abbvie; Pfizer
Consulting or Advisory Role - AstraZeneca; BEAm; Deciphera; GlaxoSmithKline; Jazz Pharmaceuticals; Kite, a Gilead company; Kronos Bio; Kura Oncology; morphosys; Newave Pharmaceutical; Pfizer; Pluristem Therapeutics; SERVIER
Patents, Royalties, Other Intellectual Property - Royalties for a chapter in Up to Date
Travel, Accommodations, Expenses - Pfizer
 
Hongtao Liu
Consulting or Advisory Role - Agios; BeiGene; CTI BioPharma Corp; NGM Biopharmaceuticals; Nkarta; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Karyopharm Therapeutics (Inst)
 
Olatoyosi Odenike
Consulting or Advisory Role - Abbvie; Blueprint Medicines; BMS; Bristol-Myers Squibb/Celgene (Inst); Celgene; CTI; Impact Biomedicines; Kymera; Novartis; SERVIER; Taiho Pharmaceutical; Threadwell therapeutics
Research Funding - Abbvie (Inst); Agios (Inst); Aprea AB (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); CTI BioPharma Corp (Inst); Daiichi Sankyo (Inst); Incyte (Inst); Janssen Oncology (Inst); Kartos Therapeutics (Inst); Loxo (Inst); Novartis (Inst); NS Pharma (Inst); OncoTherapy Science (Inst)